Fierce JPM Week 2025 - Virtual

The right real-world data can make a difference at every stage of the life sciences product life cycle – from market research and clinical trial design to go-to-market and commercialization strategies. And the right technology should deliver a unified platform experience and single source of truth across the enterprise for high-fidelity patient insights, streamlined operations, aligned decision-making, and improved therapeutic options for patients.

Join Arif Nathoo (CEO and Co-Founder of Komodo Health) and Jorge Santos da Silva (CEO and Co-Founder of MoonLake Immunotherapeutic) for a discussion on how emerging biotechs and life sciences giants alike can harness the power of a unified platform powered by regulatory-grade real-world data to transform business strategy and deliver transformative treatments to patients in need.

President-elect Donald Trump's return to the White House and Republican's control of Congress could bring significant changes to healthcare policy in the next four years. The Trump administration could make changes to the Affordable Care Act and also reshape the Medicare and Medicaid programs. Trump also has signaled an interest in tackling the rise in chronic illnesses. What will the Trump administration have in store for the evolution of value-based care and healthcare AI regulation? Hear from policy experts who will dive into what a second Trump term will mean for your business.

Medicare Advantage insurers have seen rapid growth over the past decade, with massive profits in tandem. However, cuts to federal payments, a spike in utilization and other challenges have turned this space into a huge headache for health plans. During this panel, you’ll hear from experts in the industry and beyond about what’s next for Medicare Advantage, and if the sector’s hot momentum may be over.